MRVI — Maravai Lifesciences Holdings Inc · rev $117.3M

Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.

Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.

Use this MRVI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MRVI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MRVI SEC filings page. Lician reads the product cache first so this HTML stays unique to Maravai Lifesciences Holdings Inc even when a live quote feed is slow.

Maravai Lifesciences Holdings Inc latest statements (FY2025)

Latest cached year on this hub. Full MRVI income, balance, and cash tables.

  • Revenue$185.7M
  • Net Income-$130.8M
  • Total Assets$770.6M
  • Total Debt$0
  • Free Cash Flow-$70.7M